Brief: Novartis Meets All Tender Offer Conditions To Acquire Morphosys
May 16 (Reuters) - NOVARTIS AG NOVN.S :
* NOVARTIS MEETS ALL TENDER OFFER CONDITIONS TO ACQUIRE
MORPHOSYS
AG FOR EUR 68 PER SHARE IN CASH
* SETTLEMENT OF SHARES TENDERED DURING INITIAL ACCEPTANCE
PERIOD
IS EXPECTED TO OCCUR ON 23 MAY 2024
Source text for Eikon: ID:nGNEcc97X3
Further company coverage: NOVN.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Morphosys AG
See all newsBrief: Morphosys Announces Voluntary Delisting From The Nasdaq Global Market
Brief: Morphosys Says Merger Squeeze-Out Cash Compensation Determined At Eur 68.00
Brief: Morphosys And Novartis Sign Delisting Agreement
Brief: Novartis BidCo Germany plans merger squeeze-out of Morphosys minority shareholders
Brief: Morphosys: Pichota and Lukas Gilgen replacing CEO And CFO